1
|
Blalock D, Miller A, Tilley M and Wang J:
Joint instability and osteoarthritis. Clin Med Insights Arthritis
Musculoskelet Disord. 8:15–23. 2015.PubMed/NCBI
|
2
|
Lee AS, Ellman MB, Yan D, Kroin JS, Cole
BJ, van Wijnen AJ and Im HJ: A current review of molecular
mechanisms regarding osteoarthritis and pain. Gene. 527:440–447.
2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Loeser RF, Goldring SR, Scanzello CR and
Goldring MB: Osteoarthritis: a disease of the joint as an organ.
Arthritis Rheum. 64:1697–1707. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Pereira D, Peleteiro B, Araujo J, Branco
J, Santos RA and Ramos E: The effect of osteoarthritis definition
on prevalence and incidence estimates: a systematic review.
Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc.
19:1270–1285. 2011. View Article : Google Scholar
|
5
|
Zhang Y, Jia J, Yang S, Liu X, Ye S and
Tian H: MicroRNA-21 controls the development of osteoarthritis by
targeting GDF-5 in chondrocytes. Exp Mol Med. 46:e792014.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Litwic A, Edwards MH, Dennison EM and
Cooper C: Epidemiology and burden of osteoarthritis. Br Med Bull.
105:185–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Buckwalter JA, Saltzman C and Brown T: The
impact of osteoarthritis: implications for research. Clin Orthop
Relat Res. 427(Suppl): S6–S15. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wieland HA, Michaelis M, Kirschbaum BJ and
Rudolphi KA: Osteoarthritis - an untreatable disease? Nat Rev Drug
Discov. 4:331–344. 2005. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Flower RJ: The development of COX2
inhibitors. Nat Rev Drug Discov. 2:179–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Goldring MB and Marcu KB: Epigenomic and
microRNA-mediated regulation in cartilage development, homeostasis,
and osteoarthritis. Trends Mol Med. 18:109–118. 2012. View Article : Google Scholar :
|
11
|
Wu C, Tian B, Qu X, Liu F, Tang T, Qin A,
Zhu Z and Dai K: MicroRNAs play a role in chondrogenesis and
osteoarthritis (Review). Int J Mol Med. 34:13–23. 2014.PubMed/NCBI
|
12
|
Le LT, Swingler TE and Clark IM: Review:
The role of microRNAs in osteoarthritis and chondrogenesis.
Arthritis Rheum. 65:1963–1974. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Sethupathy P and Collins FS: MicroRNA
target site polymorphisms and human disease. Trends Genet.
24:489–497. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Djuranovic S, Nahvi A and Green R:
miRNA-mediated gene silencing by translational repression followed
by mRNA deadenylation and decay. Science. 336:237–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Seeliger C1, Karpinski K, Haug AT, Vester
H, Schmitt A, Bauer JS and van Griensven M: Five freely circulating
miRNAs and bone tissue miRNAs are associated with osteoporotic
fractures. J Bone Miner Res. 29:1718–1728. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Iliopoulos D, Malizos KN, Oikonomou P and
Tsezou A: Integrative microRNA and proteomic approaches identify
novel osteoarthritis genes and their collaborative metabolic and
inflammatory networks. PLoS One. 3:e37402008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Swingler TE, Wheeler G, Carmont V, Elliott
HR, Barter MJ, Abu-Elmagd M, Donell ST, Boot-Handford RP,
Hajihosseini MK, Münsterberg A, et al: The expression and function
of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum.
64:1909–1919. 2012. View Article : Google Scholar
|
19
|
Yu C, Chen WP and Wang XH: MicroRNA in
osteoarthritis. J Int Med Res. 39:1–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Dudek KA, Lafont JE, Martinez-Sanchez A
and Murphy CL: Type II collagen expression is regulated by
tissue-specific miR-675 in human articular chondrocytes. J Biol
Chem. 285:24381–24387. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tardif G, Hum D, Pelletier JP, Duval N and
Martel-Pelletier J: Regulation of the IGFBP-5 and MMP-13 genes by
the microRNAs miR-140 and miR-27a in human osteoarthritic
chondrocytes. BMC Musculoskelet Disord. 10:1482009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bondeson J, Wainwright S, Hughes C and
Caterson B: The regulation of the ADAMTS4 and ADAMTS5 aggrecanases
in osteoarthritis: a review. Clin Exp Rheumatol. 26:139–145.
2008.PubMed/NCBI
|
23
|
Little CB and Fosang AJ: Is cartilage
matrix breakdown an appropriate therapeutic target in
osteoarthritis - insights from studies of aggrecan and collagen
proteolysis? Curr Drug Targets. 11:561–575. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Glasson SS, Askew R, Sheppard B, Carito B,
Blanchet T, Ma HL, Flannery CR, Peluso D, Kanki K, Yang Z, et al:
Deletion of active ADAMTS5 prevents cartilage degradation in a
murine model of osteoarthritis. Nature. 434:644–648. 2005.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Matsukawa T, Sakai T, Yonezawa T, Hiraiwa
H, Hamada T, Nakashima M, Ono Y, Ishizuka S, Nakahara H, Lotz MK,
et al: MicroRNA-125b regulates the expression of aggrecanase-1
(ADAMTS-4) in human osteoarthritic chondrocytes. Arthritis Res
Ther. 15:R282013. View
Article : Google Scholar : PubMed/NCBI
|
26
|
Altman R, Asch E, Bloch D, Bole G,
Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg
M, et al: Development of criteria for the classification and
reporting of osteoarthritis. Classification of osteoarthritis of
the knee Diagnostic and Therapeutic Criteria Committee of the
American Rheumatism Association. Arthritis Rheum. 29:1039–1049.
1986. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lafont JE, Talma S and Murphy CL:
Hypoxia-inducible factor 2alpha is essential for hypoxic induction
of the human articular chondrocyte phenotype. Arthritis Rheum.
56:3297–3306. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhang XJ, Ye H, Zeng CW, He B, Zhang H and
Chen YQ: Dysregulation of miR-15a and miR-214 in human pancreatic
cancer. J Hematol Oncol. 3:462010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Pieper JS, van der Kraan PM, Hafmans T,
Kamp J, Buma P, van Susante JL, van den Berg WB, Veerkamp JH and
van Kuppevelt TH: Crosslinked type II collagen matrices:
Preparation, characterization, and potential for cartilage
engineering. Biomaterials. 23:3183–3192. 2002. View Article : Google Scholar : PubMed/NCBI
|
30
|
Papaioannou G, Lisse T and Kobayashi T:
miRNAs in bone formation and homeostasis. microRNA in Regenerative
Medicine. Sen CK: Elsevier Inc; London: pp. 350–380. 2015
|
31
|
Miyaki S and Asahara H: Macro view of
microRNA function in osteoarthritis. Nat Rev Rheumatol. 8:543–552.
2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Beyer C, Zampetaki A, Lin NY, Kleyer A,
Perricone C, Iagnocco A, Distler A, Langley SR, Gelse K, Sesselmann
S, et al: Signature of circulating microRNAs in osteoarthritis. Ann
Rheum Dis. 74:e182015. View Article : Google Scholar
|
33
|
Gendron C, Kashiwagi M, Lim NH, Enghild
JJ, Thøgersen IB, Hughes C, Caterson B and Nagase H: Proteolytic
activities of human ADAMTS-5: comparative studies with ADAMTS-4. J
Biol Chem. 282:18294–18306. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Thirunavukkarasu K, Pei Y and Wei T:
Characterization of the human ADAMTS-5 (aggrecanase-2) gene
promoter. Mol Biol Rep. 34:225–231. 2007. View Article : Google Scholar : PubMed/NCBI
|
35
|
Abbaszade I, Liu RQ, Yang F, Rosenfeld SA,
Ross OH, Link JR, Ellis DM, Tortorella MD, Pratta MA, Hollis JM, et
al: Cloning and characterization of ADAMTS11, an aggrecanase from
the ADAMTS family. J Biol Chem. 274:23443–23450. 1999. View Article : Google Scholar : PubMed/NCBI
|
36
|
Tortorella MD, Burn TC, Pratta MA,
Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco
CP, Wynn R, et al: Purification and cloning of aggrecanase-1: a
member of the ADAMTS family of proteins. Science. 284:1664–1666.
1999. View Article : Google Scholar : PubMed/NCBI
|
37
|
Verma P and Dalal K: ADAMTS-4 and
ADAMTS-5: Key enzymes in osteoarthritis. J Cell Biochem.
112:3507–3514. 2011. View Article : Google Scholar : PubMed/NCBI
|
38
|
Song RHD, Tortorella MD, Malfait AM,
Alston JT, Yang Z, Arner EC and Griggs DW: Aggrecan degradation in
human articular cartilage explants is mediated by both ADAMTS-4 and
ADAMTS-5. Arthritis Rheum. 56:575–585. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Stanton H, Rogerson FM, East CJ, Golub SB,
Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, et
al: ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and
in vitro. Nature. 434:648–652. 2005. View Article : Google Scholar : PubMed/NCBI
|
40
|
Majumdar MK, Askew R, Schelling S, Stedman
N, Blanchet T, Hopkins B, Morris EA and Glasson SS: Double-knockout
of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal
animals and prevents the progression of osteoarthritis. Arthritis
Rheum. 56:3670–3674. 2007. View Article : Google Scholar : PubMed/NCBI
|
41
|
Vonk LA, Kragten AH, Dhert WJ, Saris DB
and Creemers LB: Overexpression of hsa-miR-148a promotes cartilage
production and inhibits cartilage degradation by osteoarthritic
chondrocytes. Osteoarthritis and cartilage/OARS. Osteoarthritis Res
Soc. 22:145–153. 2014. View Article : Google Scholar
|